Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.

[1]  M. Kattan,et al.  1640: Development of a Nomogram to Predict Acute Urinary Retention or BPH-Related Surgery with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial , 2005 .

[2]  M. Kattan.  Comparison of Cox regression with other methods for determining prediction models and nomograms. , 2003, The Journal of urology.

[3]  C. Roehrborn,et al.  Benign prostatic hyperplasia: a progressive disease of aging men. , 2003, Urology.

[4]  P. Boyle,et al.  Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. , 2002, Urology.

[5]  C. Roehrborn,et al.  Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. , 2002, European urology.

[6]  Michael W Kattan,et al.  Nomograms as predictive models. , 2002, Seminars in urologic oncology.

[7]  P. Boyle,et al.  Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. , 1999, Urology.

[8]  R. Roberts,et al.  Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. , 1999, The Journal of urology.

[9]  C. Roehrborn,et al.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. , 1999, Urology.

[10]  C. Roehrborn,et al.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia , 1998 .

[11]  R. Roberts,et al.  Natural history of prostatism: risk factors for acute urinary retention. , 1997, The Journal of urology.

[12]  J. Oesterling,et al.  Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. , 1996, The Journal of urology.

[13]  R. Tibshirani,et al.  An Introduction to the Bootstrap , 1995 .

[14]  E. Metter,et al.  Natural history of benign prostatichyperplasia and risk of prostatectomy , 1991 .

[15]  M. Jewett,et al.  Increasing incidence, but stable mortality, of bladder cancer in Ontario. Analysis of a population sample. , 1991, Urology.

[16]  P. Schellhammer,et al.  Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. , 2000, The Journal of urology.